Insights
From stratospheric antennas to implantable bio-sensors, from the thermodynamics of carbon capture to quantum technology and AI-designed biology, we use deep tech to challenge and change the status quo.
Read our latest research and insights to help you see beyond the innovation hype and find out how emerging technologies are solving important business problems.
Start-up technology risk management in The Engine venture ecosystem
Founders of early-stage start-ups are passionate, driven and optimistic. So, as they embark on the mission to sell their vision, they should accentuate the positive and keep negative thoughts of risk to the back of their mind, right? Wrong ...
Champions of Cell and Gene Therapy – The Medicine Maker
How do we ensure that not only the rich benefit from cell and gene therapy? Rob Collison of Cambridge Consultants says: It’s about more than cutting costs ...
Digital biomarkers for patient-empowering connected health
The future promises a digitally connected healthcare system that empowers both patients and carers alike. So, what’s the next step for pharma companies and device developers with ambitions in the space? ...
In vitro diagnostics needs seismic change to improve patient outcomes and deliver economic benefits – Technology Network
The current state of in vitro diagnostics is no longer fit for purpose. Inadequate procedures mean that critical insights are often missed, while expenditure statistics on both sides of the Atlantic reveal lagging levels of investment ...
CC and The Engine venture ecosystem: an alignment of ambition
We're ramping up our commitment to The Engine, the ambitious venture ecosystem spun out of MIT to support ‘Tough Tech’ companies and solve key challenges in climate change, human health and advanced systems ...
Getting the right distributed data architecture for you
To decentralise, or not to decentralise, that is the question. This Web3 dilemma reflects the likely thoughts of current digital leaders who want to make the best use of their digital assets while maintaining trust in their data systems ...
Can cell therapy become cheaper and easier?
Cell and gene therapy is hailed as the future of 21st century medicine but is currently too expensive to be widely used. As a principal scientist in synthetic biology, Matthew Jones is part of a team addressing this issue in ...
Neuropathy screening from diabetic retinopathy images
People with diabetes have an increased risk of developing serious health problems, including neuropathy. We’ve developed an AI-based system, in partnership with eminent specialists, to assess the presence of neuropathy from retinal images ...
Pathology: time for digital transformation?
In essence, the approach to pathology has remained unchanged for years – but is it time for pathologists to experience digital transformation powered by AI? ...
